Legend Biotech Corp (LEGN)
45.18
-1.19
(-2.57%)
USD |
NASDAQ |
May 17, 16:00
45.18
0.00 (0.00%)
After-Hours: 20:00
Legend Biotech Cash from Financing (Quarterly): 0.831M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.831M |
| December 31, 2023 | 0.925M |
| September 30, 2023 | 0.961M |
| June 30, 2023 | 790.05M |
| March 31, 2023 | -0.444M |
| December 31, 2022 | -0.783M |
| September 30, 2022 | 377.72M |
| June 30, 2022 | 1.009M |
| March 31, 2022 | 0.025M |
| December 31, 2021 | 323.56M |
| September 30, 2021 | 1.143M |
| Date | Value |
|---|---|
| June 30, 2021 | 301.75M |
| March 31, 2021 | 0.207M |
| December 31, 2020 | 0.661M |
| September 30, 2020 | 9.66M |
| June 30, 2020 | 459.80M |
| March 31, 2020 | 148.76M |
| December 31, 2019 | -6.68M |
| September 30, 2019 | -0.154M |
| June 30, 2019 | -7.177M |
| March 31, 2019 | 28.68M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-7.177M
Minimum
Jun 2019
790.05M
Maximum
Jun 2023
120.09M
Average
0.943M
Median
Cash from Financing (Quarterly) Benchmarks
| Johnson & Johnson | 546.00M |
| Bristol-Myers Squibb Co | 14.64B |
| 2seventy bio Inc | 0.386M |
| Exelixis Inc | -184.05M |
| Fortrea Holdings Inc | 21.30M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 15.52M |
| Cash from Investing (Quarterly) | -396.15M |
| Free Cash Flow | -263.24M |
| Free Cash Flow Per Share (Quarterly) | 0.0509 |
| Free Cash Flow to Equity (Quarterly) | 4.205M |
| Free Cash Flow to Firm (Quarterly) | 9.273M |
| Free Cash Flow Yield | -3.23% |